Chronic myelogenous leukemia - PubMed (original) (raw)

Review

Chronic myelogenous leukemia

M Kalidas et al. JAMA. 2001 Aug.

No abstract available

PubMed Disclaimer

Similar articles

• Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma.
  Mughal TI, Goldman JM. Mughal TI, et al. Eur J Cancer. 2001 Mar;37(5):561-8. doi: 10.1016/s0959-8049(00)00454-8. Eur J Cancer. 2001. PMID: 11290430 Review. No abstract available.
• Chronic myeloid leukemia. Introduction.
  Frame D. Frame D. Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S2-3. doi: 10.2146/ajhp070485. Am J Health Syst Pharm. 2007. PMID: 18056928 No abstract available.
• Bcr-Abl inhibition as a modality of CML therapeutics.
  Buchdunger E, Matter A, Druker BJ. Buchdunger E, et al. Biochim Biophys Acta. 2001 Aug 31;1551(1):M11-8. doi: 10.1016/s0304-419x(01)00022-1. Biochim Biophys Acta. 2001. PMID: 11553417 Review. No abstract available.
• Chronic myelogenous leukemia.
  Mauro MJ, Druker BJ. Mauro MJ, et al. Curr Opin Oncol. 2001 Jan;13(1):3-7. doi: 10.1097/00001622-200101000-00002. Curr Opin Oncol. 2001. PMID: 11148678 Review.
• 3. Imatinib therapy in chronic myelogenous leukemia.
  Jinnai I. Jinnai I. Intern Med. 2007;46(2):95-7. doi: 10.2169/internalmedicine.46.1781. Epub 2007 Jan 15. Intern Med. 2007. PMID: 17220607 Review. No abstract available.

Cited by

• Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia.
  Dalziel K, Round A, Garside R, Stein K. Dalziel K, et al. Pharmacoeconomics. 2005;23(5):515-26. doi: 10.2165/00019053-200523050-00010. Pharmacoeconomics. 2005. PMID: 15896102
• Carbenoxolone induces apoptosis and inhibits survivin and survivin-ΔEx3 genes expression in human leukemia K562 cells.
  Moosavi MA, Moasses Ghafary S, Asvadi-Kermani I, Hamzeiy H, Rahmati M, Ahmadi AH, Nikanfar A, Sanaat Z, Asadi-Khiavi M. Moosavi MA, et al. Daru. 2011;19(6):455-61. Daru. 2011. PMID: 23008692 Free PMC article.
• Association of HLA antigens and BCR-ABL transcripts in leukemia patients with the Philadelphia chromosome.
  de Carvalho DL, Barbosa CD, de Carvalho AL, Beck ST. de Carvalho DL, et al. Rev Bras Hematol Hemoter. 2012;34(4):280-4. doi: 10.5581/1516-8484.20120072. Rev Bras Hematol Hemoter. 2012. PMID: 23049441 Free PMC article.
• Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
  Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Jaiswal S, et al. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10002-7. doi: 10.1073/pnas.1633833100. Epub 2003 Jul 30. Proc Natl Acad Sci U S A. 2003. PMID: 12890867 Free PMC article.
• Imatinib: a review of its use in chronic myeloid leukaemia.
  Moen MD, McKeage K, Plosker GL, Siddiqui MA. Moen MD, et al. Drugs. 2007;67(2):299-320. doi: 10.2165/00003495-200767020-00010. Drugs. 2007. PMID: 17284091 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information